Peptide record

TPDB44067

Antiviral standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44067
Antiviral
Anti-infective peptides
AI4AVP DRAVP 2.0 Peptipedia
standard
No
A 15-aa standard-residue antiviral peptide sequence curated from AI4AVP, DRAVP 2.0, and Peptipedia, with an available 3D structural model.
Sequence
GHRYSQFMGIFEDRA
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C80H116N24O23S1
NCLKPTWV
RGF
1814.01
7.77
3
2
6
+0
2.81
-0.787
32.67
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
0.82
3
Residue Composition
number
1
A
2
R
0
N
1
D
0
C
1
E
1
Q
2
G
1
H
1
I
0
L
0
K
1
M
2
F
0
P
1
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 1 R: 2 N: 0 D: 1 C: 0 E: 1 Q: 1 G: 2 H: 1 I: 1 L: 0 K: 0 M: 1 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
15 reviewed residue count
C80H116N24O23S1 sequence-only estimate (linear, free termini)
1814.01 sequence-only estimate (linear, free termini)
7.77 sequence-only estimate (linear, free termini)
+0 sequence-only estimate (linear, free termini)
2.81 sequence-only estimate (linear, free termini)
-0.787 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0